by Michelle Ly | Feb 22, 2011
As we get further into 2011, embryonic stem (ES) cells continue to be a hot topic. The ability of ES cells to differentiate into virtually any other type of cell makes them a prime avenue for research in biomedical applications. They have also been a source of great...
by Michelle Ly | Feb 14, 2011
In previous posts, I discussed the use of cell therapy, specifically the application of allogenic or autologous hematopoietic stem cells (HSCs), as a way to repopulate blood cell lineages to normal levels post-treatment in patients suffering from certain types of...
by David Kent | Feb 11, 2011
One of the most striking observations I have made since I began my stem cell training involves the hugely positive effects of substantial resources on the field of stem cell biology. Building on the momentum of two stunning advances in developmental biology in the...
by Ubaka Ogbogu | Feb 8, 2011
A few weeks ago I blogged about the recent Supreme Court of Canada decision on the constitutional validity of several sections of the Assisted Human Reproduction Act, Canada’s assisted reproduction and embryo research legislation. I am currently preparing a paper for...
by Paul Krzyzanowski | Feb 1, 2011
Last month, The Economist published a very dismal article about PhD holder’s employment prospects entitled “The Disposable Academic”. Ouch. Nevertheless, the article made its rounds through the Internet and I received the link at least six times. It was very critical...
by Stem Cell Network | Jan 27, 2011
Earlier this week, many of the world’s leading scientists engaged in developing stem cell-based treatments for Amyotrophic Lateral Sclerosis (ALS) or Motor Neuron Disease (MND) met for the first time as a group to share their work. Held in New York, the meeting was...
by David Grant | Jan 26, 2011
How do newspaper articles portray stem cell tourism? A research team at the University of Alberta recently asked this question, and their results were published last month in the journal Nature. Their conclusions were both surprising, and hopeful. The team, led by...
by Chris Kamel | Jan 24, 2011
Although tumours are typically thought of as a single entity, the cells that make up a tumour are genetically diverse. The traditional view of cancer progression — in which a tumour arises from a single cell after accumulated mutations — suggests that...
by Stem Cell Network | Jan 20, 2011
On January 20, 2011 Ernest (“Bun”) McCulloch passed away. Although Bun was known to the young generation of stem cell researchers only by reputation, for those of us who knew him “back then” he was an icon. “Back then” was the 60s and 70s when the group led by...
by David Kent | Jan 19, 2011
Banned from receiving federal funds in 2004 by the Bush administration, human embryonic stem cell research was recently embraced by the Obama administration in March 2009 — sort of, anyway. As many readers are no doubt aware, U.S. courts are currently embroiled...
Comments